Perflubron emulsion reduces inflammation during extracorporeal circulation

Journal of Surgical Research

Volumn 99, Issue 1, 2001, Pages 7-16

  McDonagh, Paul ^a   Cerney, Kristen ^a   Hokama, Jason ^a   Lai, George ^a   Gonzales, Raoul ^a   Davis Gorman, Grace ^a   Copeland, Jack ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; CD11B ANTIGEN; FLUOSOL; PERFLUOROOCTYL BROMIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACORPOREAL CIRCULATION; HEART SURGERY; INFLAMMATION; LEUKOCYTE ACTIVATION; LUNG FUNCTION; MALE; NONHUMAN; OXYGEN TRANSPORT; PLASMALYTE; PRIORITY JOURNAL; RAT;

EID: 0034973567     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6141     Document Type: Article

References (46)

1. Effects of stimulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity
2. Humoral and cellular activation in a stimulated extracorporeal circuit
3. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation
4. Brief perfusion with diluted whole blood after global myocardial ischaemia increases reperfusion injury
5. CD18 antibody treatment limits early myocardial reperfusion injury after initial leukocyte deposition
6. Fluosol-DA: An artificial blood for total cardiopulmonary bypass
7. Reduction of myocardial ischemia during percutaneous coronary angioplasty with oxygenated fluosol
8. Hemodynamic, metabolic, and morphological effects of cardiopulmonary bypass with a fluorocarbon priming solution
9. Effect of perfluorochemical blood substitutes on human neutrophil function
10. Effects of perfluorochemical on phagocytic function of leukocytes
11. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals: Role of neutrophil activation
12. Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia
13. Phagocytic activation of human neutrophils by the detergent component of fluosol
14. The initial response of blood leukocytes to incubation with perfluorocarbon blood substitute emulsion
15. Perflubron emulsion does not cause neutrophil (PMN) activation in-vivo
16. A second-generation blood substitute (perfluorodichlorooctane emulsion) does not activate complement during an ex vivo circulation model of bypass
17. Perfluorocarbon emulsions and cardiopulmonary bypass: A technique for the future
18. Perfluorocarbons are effective oxygen carriers in cardiopulmonary bypass
19. Use of current generation perfluorocarbon emulsions in cardiac surgery
20. Perflurocarbon emulsion in the cardiopulmonary bypass prime reduces neurologic injury
21. Liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages
22. Neutrophil activation and chemotaxis after in vitro treatment with perfluorocarbon
23. A simple flow cytometric procedure for the determination of surface antigens on unfixed leucocytes in whole blood
24. Expression of functional antigens on neutrophils: Effects of preparation
25. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation
26. Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry
27. Stimulated leukocyte adhesion in coronary microcirculation is reduced by a calcium antagonist
28. Comparative adherence of granulocytes to endothelial monolayers and nylon fiber
29. The neutrophil adherence assay as a method for detecting unique anti-inflammatory agents
30. Effects of treatment with clindamycin hydrochloride on progression of canine periodontal disease after ultrasonic scaling
31. Modifications of platelet shape change and ATP release during cardiopulmonary bypass
32. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass
33. Cardiopulmonary bypass induces leukocyte-platelet adhesion
34. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function
35. The effects of complement activation during cardiopulmonary bypass: Attenuation by hypothermia, heparin, and hemodilution
36. Complement activation and neutropenia occurring during cardiopulmonary bypass
37. Organ dysfunction and cardiopulmonary bypass: The role of complement and complement regulatory proteins
38. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery
39. Occurrence of oxidative stress during reperfusion of the human heart
40. Inhibition of neutrophil adhesion during cardiopulmonary bypass
41. Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans
42. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans
43. The effect of pentoxifylline on the lung during cardiopulmonary bypass
44. Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status
45. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion
46. Effects of a novel perfluorocarbon emulsion on neutrophil chemiluminescence in human whole blood in vitro